Literature DB >> 7253653

Disease-free survival and recurrence after resection of colorectal carcinoma.

E Pihl, E S Hughes, F T McDermott, B J Milne, A B Price.   

Abstract

Recurrence data from a series of 1,315 colorectal cancer patients managed by one surgeon with potentially curative resection are presented. Complete follow-up information was available on 1,287 (98%) patients. At the time of the last recurrences, 164 and 232 months for rectal and colonic tumours respectively, the long-time recurrence rate was significantly (P = 0.001) higher for rectal tumours (42%) than for colonic (33%). Although local recurrences tended to be more common in rectal than in colonic tumours (18% compared to 15%), only those in contiguity with the operative area were significantly (P less than 0.005) more common in rectal tumours. Systemic recurrences were also significantly (P less than 0.025) commoner for rectal tumours. The greater recurrence rates in rectal tumours were associated with significantly (P less than 0.001) higher incidence of stage C tumours shorter recurrence-free survival in rectal stage C tumours (P = 0.001) and higher incidence of pulmonary metastases (P less than 0.001).

Entities:  

Mesh:

Year:  1981        PMID: 7253653     DOI: 10.1002/jso.2930160406

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Sialomucins at resection margin and likelihood of recurrence in colorectal carcinoma.

Authors:  N A Habib; P M Dawson; J W Bradfield; R C Williamson; C B Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

2.  Anastomotic Recurrence After Curative Resection for Colorectal Cancer.

Authors:  Won Beom Jung; Chang Sik Yu; Seok Byung Lim; In Ja Park; Yong Sik Yoon; Jin Cheon Kim
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.

Authors:  S L Carrithers; M T Barber; S Biswas; S J Parkinson; P K Park; S D Goldstein; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  A time saving but effective approach to the follow-up of patients after curative surgery of the large bowel.

Authors:  E S Hughes; E Pihl; F T McDermott
Journal:  Ann R Coll Surg Engl       Date:  1984-03       Impact factor: 1.891

5.  Sepsis and asepsis in large bowel cancer surgery.

Authors:  E S Hughes; F T McDermott; A L Polglase; W R Johnson; E A Pihl
Journal:  World J Surg       Date:  1982-03       Impact factor: 3.352

Review 6.  Can colorectal cancer be prevented or treated by oral hormone replacement therapy?

Authors:  P Li; J E Lin; S Schulz; G M Pitari; S A Waldman
Journal:  Curr Mol Pharmacol       Date:  2009-11       Impact factor: 3.339

7.  Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.

Authors:  Hartwig Körner; Kjetil Söreide; Pål J Stokkeland; Jon Arne Söreide
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

Review 8.  GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?

Authors:  P Li; J E Lin; G P Marszlowicz; M A Valentino; C Chang; S Schulz; G M Pitari; Scott A Waldman
Journal:  Drug News Perspect       Date:  2009 Jul-Aug

9.  Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.

Authors:  Yun-feng Shan; Xian Shen; Yuan-kang Xie; Ji-cai Chen; Hong-qi Shi; Zheng-ping Yu; Qi-tong Song; Men-tao Zhou; Qi-yu Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-10-12       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.